Skip to content
healthcare.dev
Get a free key

XELJANZ

NDC 63539-012, tofacitinib, tablet, film coated, from U.S. Pharmaceuticals.

Product NDC
63539-012
Status
Listed
Labeler
U.S. Pharmaceuticals
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203214
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63539-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE5 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
63539-012-026353900120260 TABLET, FILM COATED in 1 BOTTLE (63539-012-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/68e3d6b2-7838-4d2d-a417-09d919b43e13

Use it

Look up 63539-012 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63539-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63539-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.